Literature DB >> 12768469

Basic and clinical studies of percutaneous radiofrequency ablation of osteoid osteoma using a standard electrosurgical generator.

Akira Takeda1, Shin-Ichi Kikuchi, Takahiro Tajino, Hitoshi Yamada, Katsuhiko Sato.   

Abstract

For percutaneous radiofrequency ablation of osteoid osteoma for pain management, we used a standard electrosurgical generator instead of the radiofrequency generator system. First, we used the standard electrosurgical generator to determine the diameter of the coagulated area of normal femurs and humeruses of dogs under general anesthesia and to detect damage to normal tissue around the bone. We then used a standard electrosurgical generator to perform percutaneous radiofrequency ablation of the osteoid osteoma. All three patients were almost pain-free within the first 24 h after the procedure, and they were discharged the day after the operation, being hospitalized for only 2 days. We thus confirmed that percutaneous radiofrequency ablation using a standard electrosurgical generator produced results similar to those achieved with the radiofrequency generator system.

Entities:  

Mesh:

Year:  2003        PMID: 12768469     DOI: 10.1007/s10776-003-0640-0

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  2 in total

1.  Percutaneous radiofrequency ablation: relationship between different probe types and procedure time on length and extent of osteonecrosis in dog long bones.

Authors:  J Martel; A Bueno; M P Domínguez; P Llorens; J Quirós; C Delgado
Journal:  Skeletal Radiol       Date:  2007-11-23       Impact factor: 2.199

2.  Osteoid osteoma of the acetabulum successfully treated with computed tomography-guided resection and ablation using a standard electrosurgical generator: a case report.

Authors:  Kazutaka Kikuta; Sota Oguro; Tatsuya Yamamoto; Tetsuya Sekita; Sayaka Yamaguchi; Michiro Susa; Kazumasa Nishimoto; Masanori Inoue; Seishi Nakatsuka; Aya Sasaki; Kaori Kameyama; Masaya Nakamura; Morio Matsumoto; Hideo Morioka
Journal:  J Med Case Rep       Date:  2016-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.